“…Human SFPQ lies in a region on chromosome 1p34-p36 already implicated in speech anomalies and language impairment and has been found to be mis-regulated in brains of patients with a variety of neurodegenerative disorders such as autism and dyslexia (Chang et al, 2015;Ke et al, 2012;Stamova et al, 2013;Tapia-Paez et al, 2008) . The SFPQ protein is conserved across species and plays a key role in neuronal development and network organization (Thomas-Jinu et al, 2017). The protein structure contains tandem RNA recognition motif domains, a NOPS domain, a coiled-coil region and an N-terminal proline/glutamine-rich low-complexity region (Passon et al, 2012).. More recently, loss of SFPQ function has been implicated as a risk factor for human neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), fronto-temporal dementia (FTD) and Alzheimer's Disease (AD) (Ishigaki et al, 2017;Luisier et al, 2018;Takayama et al, 2019;Thomas-Jinu et al, 2017) in mouse, iPSC, and zebrafish models.…”